News

Regeneron Pharmaceuticals Is My Top Pick In The Biotech Space

4/04/16

Article includes shapshot of corporate event data from Wall Street Horizon as it factors into the analysis of REGN...

Read More

My Thoughts On Gilead Sciences' Patent Loss

3/28/16

How will Gilead's forthcoming earnings release impact the share price? Check out Seeking Alpha's detailed analysis...

Read More

AbbVie Superior Dividend Makes It A Top Choice In The Health Care Sector

3/22/16

Critical corporate event data from Wall Street Horizon featured as author Alexander Poulos delves into the growth of ABBV...

Read More

Pfizer Is Poised For Long-Term Outperformance

3/21/16

See how Enchilada helped with PFE and AGN merger analysis...

Read More

What Zydelig's Failure Means For Gilead Investors

3/21/16

See how GILD's upcoming earnings announcement among other factors may affect the stock price...

Read More

WSH Incorporates Drug Approval Dates from BioMedTracker for Pharma Traders

2/18/16

The dataset will provide all relevant and potentially market-moving event dates around drug trials and approvals....

Read More

Wall Street Horizon Partners with Informa’s BioMedTracker to provide FDA Drug Approval Dates and Pharmaceutical Intelligence to Investment Professionals

2/18/16

New partnership will give clients access to PDUFA dates, through Enchilada, its new online application...

Read More

Wall Street Horizon Adds API, Expands Event Types

12/16/15

Wall Street Horizon has rolled out an API for financial firms to access data from its Enchilada platform, plus three new corporate event types...

Read More